Patent 9714421 was granted and assigned to Ionis Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.